Academic Journal
View in EDS

Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer

Bibliographic Details
Title: Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
Authors: Feizhi Lin, Yongming Chen, Bowen Huang, Shenghang Ruan, Jun Lin, Zewei Chen, Chunyu Huang, Baiwei Zhao
Source: Frontiers in Pharmacology, Vol 15 (2024)
Publisher Information: Frontiers Media S.A., 2024.
Publication Year: 2024
Collection: LCC:Therapeutics. Pharmacology
Subject Terms: perioperative treatment, gastric cancer, immunotherapy, neoadjuvant therapy, adjuvant therapy, chemotherapy, Therapeutics. Pharmacology, RM1-950
More Details: Gastric/gastroesophageal junction (G/GEJ) cancer represents a significant global health challenge. Radical surgery remains the cornerstone of treatment for resectable G/GEJ cancer. Supported by robust evidence from multiple clinical studies, therapeutic approaches, including adjuvant chemotherapy or chemoradiation, and perioperative chemotherapy, are generally recommended to reduce the risk of recurrence and enhance long-term survival outcomes post-surgery. In recent years, immune checkpoint inhibitors (ICIs) have altered the landscape of systemic treatment for advanced or metastatic G/GEJ cancer, becoming the standard first-line therapy for specific patients. Consequently, exploring the efficacy of ICIs in the adjuvant or neoadjuvant setting for resectable G/GEJ cancer is worthwhile. This review summarizes the current advances in the application of ICIs for resectable G/GEJ cancer.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 1663-9812
Relation: https://www.frontiersin.org/articles/10.3389/fphar.2024.1391562/full; https://doaj.org/toc/1663-9812
DOI: 10.3389/fphar.2024.1391562
Access URL: https://doaj.org/article/6c08046cccef4fc3bec2a8c16060a70e
Accession Number: edsdoj.6c08046cccef4fc3bec2a8c16060a70e
Database: Directory of Open Access Journals
FullText Text:
  Availability: 0
CustomLinks:
  – Url: https://resolver.ebsco.com/c/xy5jbn/result?sid=EBSCO:edsdoj&genre=article&issn=16639812&ISBN=&volume=15&issue=&date=20240501&spage=&pages=&title=Frontiers in Pharmacology&atitle=Application%20of%20immune%20checkpoint%20inhibitors%20for%20resectable%20gastric%2Fgastroesophageal%20cancer&aulast=Feizhi%20Lin&id=DOI:10.3389/fphar.2024.1391562
    Name: Full Text Finder (for New FTF UI) (s8985755)
    Category: fullText
    Text: Find It @ SCU Libraries
    MouseOverText: Find It @ SCU Libraries
  – Url: https://doaj.org/article/6c08046cccef4fc3bec2a8c16060a70e
    Name: EDS - DOAJ (s8985755)
    Category: fullText
    Text: View record from DOAJ
    MouseOverText: View record from DOAJ
Header DbId: edsdoj
DbLabel: Directory of Open Access Journals
An: edsdoj.6c08046cccef4fc3bec2a8c16060a70e
RelevancyScore: 1008
AccessLevel: 3
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 1008.02886962891
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Feizhi+Lin%22">Feizhi Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Yongming+Chen%22">Yongming Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Bowen+Huang%22">Bowen Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Shenghang+Ruan%22">Shenghang Ruan</searchLink><br /><searchLink fieldCode="AR" term="%22Jun+Lin%22">Jun Lin</searchLink><br /><searchLink fieldCode="AR" term="%22Zewei+Chen%22">Zewei Chen</searchLink><br /><searchLink fieldCode="AR" term="%22Chunyu+Huang%22">Chunyu Huang</searchLink><br /><searchLink fieldCode="AR" term="%22Baiwei+Zhao%22">Baiwei Zhao</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: Frontiers in Pharmacology, Vol 15 (2024)
– Name: Publisher
  Label: Publisher Information
  Group: PubInfo
  Data: Frontiers Media S.A., 2024.
– Name: DatePubCY
  Label: Publication Year
  Group: Date
  Data: 2024
– Name: Subset
  Label: Collection
  Group: HoldingsInfo
  Data: LCC:Therapeutics. Pharmacology
– Name: Subject
  Label: Subject Terms
  Group: Su
  Data: <searchLink fieldCode="DE" term="%22perioperative+treatment%22">perioperative treatment</searchLink><br /><searchLink fieldCode="DE" term="%22gastric+cancer%22">gastric cancer</searchLink><br /><searchLink fieldCode="DE" term="%22immunotherapy%22">immunotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22neoadjuvant+therapy%22">neoadjuvant therapy</searchLink><br /><searchLink fieldCode="DE" term="%22adjuvant+therapy%22">adjuvant therapy</searchLink><br /><searchLink fieldCode="DE" term="%22chemotherapy%22">chemotherapy</searchLink><br /><searchLink fieldCode="DE" term="%22Therapeutics%2E+Pharmacology%22">Therapeutics. Pharmacology</searchLink><br /><searchLink fieldCode="DE" term="%22RM1-950%22">RM1-950</searchLink>
– Name: Abstract
  Label: Description
  Group: Ab
  Data: Gastric/gastroesophageal junction (G/GEJ) cancer represents a significant global health challenge. Radical surgery remains the cornerstone of treatment for resectable G/GEJ cancer. Supported by robust evidence from multiple clinical studies, therapeutic approaches, including adjuvant chemotherapy or chemoradiation, and perioperative chemotherapy, are generally recommended to reduce the risk of recurrence and enhance long-term survival outcomes post-surgery. In recent years, immune checkpoint inhibitors (ICIs) have altered the landscape of systemic treatment for advanced or metastatic G/GEJ cancer, becoming the standard first-line therapy for specific patients. Consequently, exploring the efficacy of ICIs in the adjuvant or neoadjuvant setting for resectable G/GEJ cancer is worthwhile. This review summarizes the current advances in the application of ICIs for resectable G/GEJ cancer.
– Name: TypeDocument
  Label: Document Type
  Group: TypDoc
  Data: article
– Name: Format
  Label: File Description
  Group: SrcInfo
  Data: electronic resource
– Name: Language
  Label: Language
  Group: Lang
  Data: English
– Name: ISSN
  Label: ISSN
  Group: ISSN
  Data: 1663-9812
– Name: NoteTitleSource
  Label: Relation
  Group: SrcInfo
  Data: https://www.frontiersin.org/articles/10.3389/fphar.2024.1391562/full; https://doaj.org/toc/1663-9812
– Name: DOI
  Label: DOI
  Group: ID
  Data: 10.3389/fphar.2024.1391562
– Name: URL
  Label: Access URL
  Group: URL
  Data: <link linkTarget="URL" linkTerm="https://doaj.org/article/6c08046cccef4fc3bec2a8c16060a70e" linkWindow="_blank">https://doaj.org/article/6c08046cccef4fc3bec2a8c16060a70e</link>
– Name: AN
  Label: Accession Number
  Group: ID
  Data: edsdoj.6c08046cccef4fc3bec2a8c16060a70e
PLink https://login.libproxy.scu.edu/login?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.6c08046cccef4fc3bec2a8c16060a70e
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fphar.2024.1391562
    Languages:
      – Text: English
    Subjects:
      – SubjectFull: perioperative treatment
        Type: general
      – SubjectFull: gastric cancer
        Type: general
      – SubjectFull: immunotherapy
        Type: general
      – SubjectFull: neoadjuvant therapy
        Type: general
      – SubjectFull: adjuvant therapy
        Type: general
      – SubjectFull: chemotherapy
        Type: general
      – SubjectFull: Therapeutics. Pharmacology
        Type: general
      – SubjectFull: RM1-950
        Type: general
    Titles:
      – TitleFull: Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Feizhi Lin
      – PersonEntity:
          Name:
            NameFull: Yongming Chen
      – PersonEntity:
          Name:
            NameFull: Bowen Huang
      – PersonEntity:
          Name:
            NameFull: Shenghang Ruan
      – PersonEntity:
          Name:
            NameFull: Jun Lin
      – PersonEntity:
          Name:
            NameFull: Zewei Chen
      – PersonEntity:
          Name:
            NameFull: Chunyu Huang
      – PersonEntity:
          Name:
            NameFull: Baiwei Zhao
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 16639812
          Numbering:
            – Type: volume
              Value: 15
          Titles:
            – TitleFull: Frontiers in Pharmacology
              Type: main
ResultId 1